HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
NET
Cloudflare, Inc.
NET lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
NET Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Unavailable |
NET's revenue and cash flow are currently strong, but its profitability is weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
NET PE Valuation
NET has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
NET Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
NET has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over NET on earnings, with more consistent year-over-year improvement.
NET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.75 | — |
| Q3 2026 | -$0.68 | -$0.37 |
| Q2 2026 | -$0.58 | -$0.23 |
| Q1 2026 | -$0.25 | -$0.01 |
| Q4 2025 | -$0.29 | -$0.06 |
| Q3 2025 | -$0.31 | -$0.05 |
| Q2 2025 | -$0.35 | -$0.06 |
| Q1 2025 | -$0.24 | +$0.29 |
| Q4 2024 | -$0.23 | +$0.32 |
NET is still losing money, but less than at its worst: $0.68 per share over the past year, against $0.91 at its worst in mid-2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over NET on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over NET on profitability, with a higher operating margin.
NET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $782.5M | +39% |
| Q2 2026 | $696.1M | +36% |
| Q1 2026 | $639.8M | +34% |
| Q4 2025 | $614.5M | +34% |
| Q3 2025 | $562M | +31% |
| Q2 2025 | $512.3M | +28% |
| Q1 2025 | $479.1M | +27% |
| Q4 2024 | $459.9M | +27% |
NET's revenue has grown year over year every quarter since late 2020: $783M last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.7% | -2 points |
| Q2 2026 | -30% | -16 points |
| Q1 2026 | -9.7% | +1.4 points |
| Q4 2025 | -8% | -0.5 points |
| Q3 2025 | -6.7% | +0.5 points |
| Q2 2025 | -13% | -4.5 points |
| Q1 2025 | -11% | +3.3 points |
| Q4 2024 | -7.5% | +4.3 points |
NET's operating margin was −8.7% last quarter, down 2 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over NET on cash flow, with more consistent year-over-year improvement.
NET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $93.6M | +13% |
| Q2 2026 | $67.6M | +69% |
| Q1 2026 | $93.1M | +55% |
| Q4 2025 | $105.2M | +94% |
| Q3 2025 | $82.5M | +51% |
| Q2 2025 | $39.9M | -12% |
| Q1 2025 | $59.9M | +44% |
| Q4 2024 | $54.2M | -0.9% |
NET generated $359M in free cash flow over the past year, up 52% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
NET Net Leverage
NET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
NET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 37.6 | Neutral |
NET's weekly RSI is 56 (neutral) and its Stochastic is 38 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
NET PE vs Technology Sector
NET has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
NET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $318.6 | 0% below |
| 20 week MA | $299.8 | 6.2% above |
| 50 week MA | $241.0 | 32% above |
| 100 week MA | $204.9 | 55% above |
| 200 week MA | $139.8 | 128% above |
NET has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
NET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $85.0 | +409% |
| 2021 | $85.0 | $137.3 | +62% |
| 2022 | $137.3 | $43.8 | -68% |
| 2023 | $43.8 | $83.3 | +90% |
| 2024 | $83.3 | $110.6 | +33% |
| 2025 | $110.6 | $202.4 | +83% |
| 2026 YTD | $202.4 | $318.5 | +57% |
NET has the edge over HIMS on returns for 2026, with the stronger performance.